Staar Surgical STAA Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Staar Surgical STAA

STAA 25.26

-2.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: gcrispin who wrote (24)	5/1/1999 7:40:00 PM
From: Alan A. Hicks	of 50

The ICL is a very, very thin lens made from a collagen/polymer material that is actually 30% water. It is designed to be a very biocompatible material in the eye. When injected, it unfolds and rests in a natural pocket, the posterior chamber, between the natural lens and the iris. The ICL has been used for over five years internationally and is in its 5th generation of design. Surgeons have perfected the techniques to address issues affecting the ICL. It has been designed to have a "vault" that keeps it above the natural lens and does not rub against it. Also, it has been found is that a very important issue is placing the proper size ICL for the patient's eye. All eyes are a little different in size. If the ICL is too small for the patient, it could move around in the eye. With the proper sized ICL, there has been no problem with the ICL moving off center. Data from the FDA trials are showing both safe and effective results.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next